NantHealth Inc (NH)

NantHealth Welcomes Scott Maratea as Chief Revenue Officer to Executive Team

NantHealth, Inc. (NASDAQ-GS: NH), is pleased to announce the appointment of Scott Maratea as Chief Revenue Officer. Scott has spent the last...

NantHealth Achieves NCQA Accreditation in Utilization Management

NantHealth, Inc. (NASDAQ-GS: NH), proudly announces that its Utilization Management Program has earned a 3-year reaccreditation from the National...

NantHealth Welcomes Marc Harrison as Chief Legal Officer to Executive Team

NantHealth, Inc. (NASDAQ-GS: NH), proudly announces the appointment of Marc Harrison as Chief Legal Officer, further strengthening its executive...

NantHealth Strengthens Product Leadership Team to Drive Innovation in Healthcare Technology

NantHealth, Inc. (NASDAQ-GS: NH), proudly announces the expansion of its product leadership team by appointing three seasoned executives who will...

Form EFFECT - Notice of Effectiveness

Form EFFECT - Notice of Effectiveness

Form POS AM - Post-Effective amendments for registration statement

Form POS AM - Post-Effective amendments for registration statement

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form 8-K - Current report

Form 8-K - Current report

Form 8-K - Current report

Form 3 - Initial statement of beneficial ownership of securities